Instil Bio Inc reports results for the quarter ended in June - Earnings Summary

Instil Bio

14/08/2024 24:15

* Instil Bio Inc  TIL.OQ  reported a quarterly adjusted loss
of
$2.29​​ per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of
$-2.80.  The mean expectation of two analysts for the quarter
was for a loss of $2.98 per share. Wall Street expected
results to range from $-3.04 to $-2.92 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Instil Bio Inc's reported EPS for the quarter was a loss
of
$2.29​.
    * The company reported a quarterly loss of $14.92 million.
    * Instil Bio Inc shares had risen by 2.8% this quarter and
gained 38.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Instil Bio Inc is
$18.00 
This summary was machine generated from LSEG data August 13 at
11:15 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jan. 1 0001       -2.98          -2.29          Beat
 Mar. 31 2024      -2.23          -3.74          Missed
 Dec. 31 2023      -2.84          -1.99          Beat
 Sep. 30 2023      -2.00          -10.40         Missed